Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia

The treatment (i.e. therapy and management) of chronic lymphocytic leukemia (i.e. the disease) has been improved thanks to the introduction (i.e. approval) of kinase inhibitors during the last years. PI3K is one of the most important kinases at the crossroad to the B-cell receptor and cytokine recep...

Descripción completa

Detalles Bibliográficos
Autores principales: Visentin, Andrea, Frezzato, Federica, Severin, Filippo, Imbergamo, Silvia, Pravato, Stefano, Romano Gargarella, Leila, Manni, Sabrina, Pizzo, Serena, Ruggieri, Edoardo, Facco, Monica, Brunati, Anna Maria, Semenzato, Gianpietro, Piazza, Francesco, Trentin, Livio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532889/
https://www.ncbi.nlm.nih.gov/pubmed/33061448
http://dx.doi.org/10.2147/OTT.S268899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532889/
https://www.ncbi.nlm.nih.gov/pubmed/33061448
http://dx.doi.org/10.2147/OTT.S268899

Ejemplares similares